Navigation Links
Hepatitis C therapy: Inhibiting newly discovered microDNA molecule

Last fall Dr. Peter Sarnow and a team of Stanford University scientists reported that the hepatitis C virus needs a specific microRNA, named miR-122, in order to replicate in cultured liver cells.

When the scientists inactivated the microRNA, the amount of hepatitis C virus RNA was reduced by approximately 80 percent. The discovery was widely heralded for its potential to develop new antiviral agents against hepatitis C, the most common blood-borne viral infection in the United States, affecting more than 2.5 million Americans and a staggering 170 million people worldwide. The best treatment regimens now available are difficult, expensive, laden with serious side effects and effective in only half the cases.

Dr. Sarnow discusses the most recent findings in this work on April 5 at Experimental Biology 2006 in San Francisco. His presentation is part of the scientific program of the American Society for Biochemistry and Molecular Biology.

MicroRNAs, or miRNAs for short, are small RNA molecules that regulate genes in many plant and animal species. Although miRNAs were not discovered until the mid-1990, a growing number of studies suggest that over 300 human genes encode microRNAs and that these microRNAs may control gene expression for as much as a third of the human genome, acting as key regulators of processes as diverse as early development, cell proliferation and cell death, and cell differentiation. Some miRNAs are located throughout the body, while others are found only in specific tissue. The miRNA whose surprising new role was discovered by Dr. Sarnow and his colleagues is located only in the liver. The Sarnow team found that miR-122 binds to a specific noncoding binding region in virus, called target 5' NCR. This is the first example of an animal RNA that interacts with its target 5' NCR, and opens an interesting possibility that other viral 5' NCRs are similarly targeted by different miRNAs.


'"/>

Source:Federation of American Societies for Experimental Biology


Page: 1

Related biology news :

1. Scientists Replicate Hepatitis C Virus in Laboratory
2. Norovirus, AIDS vaccine and Hepatitis Virus
3. UCLA study assesses cost-effectiveness of Hepatitis B drugs
4. Natural Killers Could Lead to New Hepatitis Treatments
5. FDA Approves New Treatment for Chronic Hepatitis B
6. Identification of specific genes predicts which patients will respond to Hepatitis C treatment
7. Hepatitis C responds best to combo of ribavirin and interferon, study concludes
8. Use of high hydrostatic pressure to inactivate Hepatitis A virus in oysters studied
9. Hepatitis C complicated by morphine withdrawal
10. Hepatitis B accounts for 40 percent of missing Asian women
11. Hepatitis E takes a piggyback
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2018)... , ... August 14, 2018 , ... ... depicted in the movie “Wonder,” to a better understanding of congenital heart defects, ... to editors of the latest special issue of Birth Defects Research ...
(Date:8/7/2018)... ... 2018 , ... Nurse practitioners and physician ... healthcare careers in the past year, according to the second annual survey of ... with a wide variety of career- and employment-related resources including physician/candidate database, job ...
(Date:8/7/2018)... JORDAN, Utah (PRWEB) , ... August 07, 2018 , ... ... solutions, announced today their new CT Cloud Voice and SIP solutions. CT Cloud ... scalable and secure, quality voice solution that is far superior to traditional PBX systems, ...
Breaking Biology News(10 mins):
(Date:8/17/2018)... Kan. (PRWEB) , ... August 16, 2018 , ... ... research organization (CRO) is pleased to announce the expansion of their team. Dr. ... was hired to launch an innovative large molecule LC-MS/MS group that will specialize ...
(Date:8/14/2018)... , ... August 14, 2018 , ... ... for treating opioid use disorder. BUP is often prescribed as a sublingual co-formulation ... , In this webinar, participants will learn from a review of the ...
(Date:8/9/2018)... , ... August 08, 2018 , ... ... service was developed and is continually updated by a talented scientific team that ... integrated service provides: , 1. Information on the medical impact of a ...
(Date:8/9/2018)... Pa. (PRWEB) , ... August 09, 2018 , ... ... Chief Science Officer at Rockland, and Dr. Birte Aggeler, Director of Antibody Development ... 50 years. The review article was published online on August 9, 2018 and ...
Breaking Biology Technology: